ME Pangali Forward P/E 23andMe Holding Co.

Logo korporat perusahaan 23andMe Inc. (ME)

The potential of 23andMe Holding Co. (ME) is based on the commercialization of biodata through pharma partnerships and the demand for DNA tests. The projected valuation based on the company's P/E ratio visualizes these expectations, with the metric holding around 0.00. However, the current chart is clouded by a critical crisis: cyberattacks, a collapse in subscriptions, and the threat of bankruptcy create extreme risks of the shares being delisted from the exchange.

Kapitalisasi marang proyeksi bathi: 23andMe (ME) kanggo 04.07.2022 - 05.04.2025

Rincian analitis perusahaan 23andMe Holding Co.

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:23andMe Holding Co.
Produk merek 23andMe Holding Co.

The forward P/E ratio relates the current share price to expected earnings, allowing for an assessment of the premium paid for the business's future income. By analyzing changes in the forward price-to-earnings multiple of 23andMe Holding Co. (ME), an investor can observe the market's reaction to operational reports, which in the case of 23andMe Holding Co. (ME) reflects the critical risk of bankruptcy and delisting amid the collapse of its subscription model and the aftermath of cyberattacks.

Karo sapa 23andMe Holding Co. saingan

Pangali Forward P/E A|DGX - Rasio prakiraan rega marang bathi|Illumina Inc - Prakiraan rega marang bathi|exactsciences.com (EXAS) - Rasio prakiraan rega marang bathi|RVTY - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Bio-Rad Laboratories, Inc. BIO|NNNN: Pangali Forward P/E|SHC - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep quidel.com|Rasio prakiraan rega marang bathi opko.com OPK|Pangali Forward P/E CDNA|Prakiraan rega marang bathi Maravai LifeSciences Holdings, Inc. MRVI|Fulgent Genetics Inc - Prakiraan rega marang bathi|Pangali Forward P/E Standard BioTools Corp LAB|CTKB: Prakiraan rega marang bathi|OSUR - Pangali Forward P/E|XGN: Pangali Forward P/E|MDxHealth - Pangali mangsa ngarep rega marang bathi|LUCD (Lucid Diagnostics Inc.) - Pangali Forward P/E|PRE (Prenetics Global) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E IMDX|Rasio kapitalisasi marang bathi mangsa ngarep TRIB|Rega marang bathi mangsa ngarep ProPhase Labs Inc PRPH|Kapitalisasi marang proyeksi bathi Ainos Inc (AIMD)|CODX - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Heart Test Labs|BMRA: Pangali Forward P/E|CDIO - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi ONCO|Rega marang bathi mangsa ngarep VRAX|Pangali Forward P/E BJDX|Aspira Women's Health Inc - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E AXDX (Accelerate Diagnostics, Inc.)|Kapitalisasi marang proyeksi bathi Centogene N.V. (CNTG)|Enzo Biochem Inc. - Pangali Forward P/E|FRES: Rega marang bathi mangsa ngarep|gtglabs.com (GENE) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep PMD